XML 65 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Cash flows from operating activities    
Net loss $ (42,881) $ (30,447)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,694 3,912
Loss on disposal of property and equipment 6 26
Unrealized (appreciation) depreciation on equity securities 21,635 (15,971)
Amortization of discount/premium of short term investments 51  
Equity in net loss of affiliate 390  
Gain on previously held equity investment (7,415)  
Stock-based compensation expense 1,196 520
Contribution of services by shareholder 775 775
Shares issued to nonemployee members of the Board of Directors 85 76
Receivables:    
Trade (112) (178)
Related parties (489) (260)
Other (184) 933
Prepaid expenses and other 747 (605)
Other assets (7,547) 311
Accounts payable 722 (582)
Accrued compensation and benefits (537) 1,273
Other accrued liabilities 39 (754)
Deferred revenue 2,311 7,246
Related party payables (89) (249)
Other long term liabilities (10) 58
Net cash used in operating activities (27,613) (33,916)
Cash flows from investing activities    
Purchases of short term investments (95,246) (1)
Purchases of equity securities   (10,000)
Acquisition of business, net of cash received 512  
Purchases of property and equipment (776) (6,965)
Proceeds from sale of property and equipment   5
Issuance of related party note receivable (300)  
Proceeds from related party notes receivable 500 34
Net cash used in investing activities (95,310) (16,927)
Cash flows from financing activities    
Payments of capital lease obligations (34) (38)
Proceeds from long term debt 171  
Payments of long term debt (18)  
Proceeds from stock option exercises 9 184
Payment of stock issuance costs (3,148) (11)
Net cash provided by financing activities 146,980 50,546
Effect of exchange rate changes on cash and cash equivalents 1  
Net increase (decrease) in cash and cash equivalents 24,058 (297)
Cash and cash equivalents    
Beginning of period 10,403 19,628
End of period 34,461 19,331
Supplemental disclosure of cash flow information    
Cash paid during the period for interest 48 6
Significant noncash financing and investing activities    
Accretion of dividends on redeemable convertible preferred shares 14,347 10,822
Stock received as consideration for collaboration agreements 3,732 6,588
IPO fees included in accrued expenses 1,526  
Series E Redeemable Convertible Preferred Stock [Member]
   
Cash flows from financing activities    
Proceeds from issuance of redeemable convertible preferred shares   50,560
Significant noncash financing and investing activities    
Accretion of dividends on redeemable convertible preferred shares 6,383  
Series F Redeemable Convertible Preferred Stock [Member]
   
Cash flows from financing activities    
Proceeds from issuance of redeemable convertible preferred shares 150,000  
Significant noncash financing and investing activities    
Accretion of dividends on redeemable convertible preferred shares 2,139  
Subscriptions Payable [Member] | Series E Redeemable Convertible Preferred Stock [Member]
   
Significant noncash financing and investing activities    
Conversion of subscriptions payable into Series E redeemable convertible preferred shares   $ 7,440